Search

Researchers from Memorial Sloan Kettering Cancer Center (MSK) and their colleagues at the University of Pennsylvania (UPenn), in collaboration with the Parker Institute for Cancer Immunotherapy (PICI), studied changes in the blood of patients with stage IV melanoma who were all treated with the PD-1 drug pembrolizumab. Researchers looked at circulating immune cells called T cells that showed signs of being “reinvigorated” by the PD-1 therapy. For more information or to arrange interviews please e-mail Rebecca Williams at [email protected].

… Monday, April 10, 2017 Bottom Line :  Researchers from  Memorial Sloan Kettering Cancer Center  (MSK) and their colleagues at the University of Pennsylvania (UPenn), in collaboration with the Parker Institute for Cancer Immunotherapy (PICI), studied changes in the blood of patients with stage IV melanoma

Social worker Barbara Golby gives advice for restoring confidence, setting expectations, and disclosing disease history to cancer patients and survivors looking to jump into the dating scene.

… Thursday, February 11, 2016 Summary Having cancer or a history of the disease can make the search for a relationship seem intimidating. Social worker Barbara Golby gives advice for restoring confidence, setting expectations, and disclosing disease history and shares  resources for cancer patients and

After a relapse of sickle cell disease, Armani Rodriguez and his family found new hope and a special bond with Dr. Maria Cancio at MSK Kids.

… Tuesday, October 29, 2024 Armani Rodriguez was only 2 months old when he spent his very first Christmas in a hospital. Now 22 years old, the Brooklyn native can’t recall the searing pain that landed him there, but his mom will never forget. “He was always crying and needing pain medication,” says Awilda

Memorial Medical Care, PC, a practice of Memorial Sloan Kettering Cancer Center physicians, in collaboration with New York Cancer & Blood Specialists (NYCBS), recently announced the opening of a new comprehensive cancer care practice in the Flatbush section of Brooklyn.

… Wednesday, January 4, 2023 New York Cancer & Blood Specialists (NYCBS), one of the fastest-growing community oncology practices in the nation, today announced the opening of a new comprehensive cancer care practice in the Flatbush section of Brooklyn in collaboration with Memorial Medical Care, PC (MMC

The Memorial Sloan Kettering Cancer Center (MSK) community extends our congratulations to Board of Trustees member David M. Rubenstein, who received the Presidential Medal of Freedom — the nation’s highest civilian honor — earlier this month.

… Wednesday, January 22, 2025 David M. Rubenstein The Memorial Sloan Kettering Cancer Center (MSK) community extends our congratulations to Board of Trustees member David M. Rubenstein, who received the Presidential Medal of Freedom — the nation’s highest civilian honor — earlier this month. During a ceremony

A carefully monitored, multidisciplinary watch-and-wait strategy can result in excellent rectal preservation and pelvic tumor control for a large majority of select patients with rectal cancer who show a clinical complete response after neoadjuvant therapy.

… Friday, March 1, 2019 A carefully monitored, multidisciplinary watch-and-wait strategy can result in excellent rectal preservation and pelvic tumor control for a large majority of select patients with rectal cancer who show a clinical complete response after neoadjuvant therapy, according to our recent

New MSK research reveals how dormant metastatic cancer cells protect themselves from the immune system by changing their shape.

… Thursday, January 15, 2026 Cancer cells that have broken away from a primary tumor can lurk in the body for years in a dormant state, evading immune defenders and biding their time until conditions are ripe for establishing a new tumor elsewhere in the body, a process known as metastasis. The vast majority

Discoveries made at Memorial Sloan Kettering receive recognition at the 2014 Annual Meeting of the American Association for Cancer Research.

… Thursday, April 10, 2014 Summary Discoveries made at Memorial Sloan Kettering receive recognition at the 2014 Annual Meeting of the American Association for Cancer Research. Two Memorial Sloan Kettering studies about targeted cancer therapies received recognition in the press program for one of the nation

Tobias M. Hohl, MD, PhD, Chief of the Infectious Diseases Service in the Department of Medicine, was elected a 2022 Fellow of the American Association for the Advancement of Science (AAAS), the world’s largest scientific society and publisher of the Science journals. This title is one of the most distinguished honors within the scientific community and is designed to recognize leaders for their notable contributions to science.

… Friday, February 3, 2023 Tobias M. Hohl, MD, PhD , Chief of the Infectious Diseases Service in the Department of Medicine, was elected a 2022 Fellow of the American Association for the Advancement of Science  (AAAS), the world’s largest scientific society and publisher of the  Science journals. This

Read a letter from Memorial Sloan Kettering's leadership team about our commitment to our community in response to acts of racism and discrimination.

… Tuesday, June 2, 2020 We are deeply saddened by the senseless and devastating acts of racism and discrimination occurring across the country. They have no place in our communities or workplaces. It rests in our hands to do what is right, to work together to fight injustice and to be part of the solution